Senate panel clears bill to allow telehealth treatment for obesity with safeguards

The Senate Health and Welfare Committee on March 11 reported SB 30, a bill to remove state-level restrictions that have limited use of telehealth for treating obesity and related metabolic conditions. The committee adopted an amendment requiring synchronous, real‑time video encounters and reported the bill favorable as amended.

Sponsor explained the restriction dates to when primary weight‑loss medications were controlled substances and that recent advances make telehealth treatment for obesity both feasible and an access issue. "SB 30 would provide that no state agency...shall adopt or enforce any rule or policy that prohibits or restricts a licensed health care provider from using telehealth to evaluate, diagnose, or treat obesity," the sponsor said, and the adopted amendment emphasizes synchronous live video to ensure direct clinician‑patient interaction.

Testimony included representatives from the Louisiana State Board of Medical Examiners, which said the obesity and telehealth rules were written years ago and are being updated. Dr. May Scott, a Metairie physician, praised the medicines' results but urged oversight: "This medicine is fantastic and we see very few problems, but it is not without its dangers," she said, calling for clear regulatory oversight and authority for the medical board to supervise providers and ensure patient safety.

Committee members and witnesses discussed licensure, pharmacy oversight and the role of Louisiana‑licensed prescribers and in‑state pharmacies; supporters argued the change would improve access in rural areas. After adopting amendment 7-35 (synchronous telehealth language) by voice consent, the committee reported SB 30 favorable as amended.